Ciprofloxacin-induced	ciprofloxacin-induced	O	O
acute	acute	O	B_disease
interstitial	interstitial	O	B_disease
nephritis	nephritis	O	I_disease
and	and	O	O
autoimmune	autoimmune	O	B_disease
hemolytic	hemolytic	O	B_disease
anemia	anemia	O	S_disease
.	.	O	O

Ciprofloxacin	ciprofloxacin	S_chemical	O
has	has	O	O
been	been	O	O
associated	associated	O	B_disease
with	with	O	I_disease
several	several	O	O
side	side	O	B_disease
effects	effects	O	I_disease
including	including	O	O
interstitial	interstitial	O	B_disease
nephritis	nephritis	O	I_disease
and	and	O	O
hemolytic	hemolytic	O	B_disease
anemia	anemia	O	S_disease
.	.	O	O

The	the	O	O
combination	combination	O	O
of	of	O	O
both	both	O	O
side	side	O	B_disease
effects	effects	O	I_disease
is	is	O	O
extremely	extremely	O	O
rare	rare	O	O
.	.	O	O

In	in	O	O
this	this	O	O
report	report	O	O
,	,	O	O
we	we	O	O
describe	describe	O	O
a	a	O	O
case	case	O	O
of	of	O	O
ciprofloxacin-induced	ciprofloxacin-induced	O	O
interstitial	interstitial	O	B_disease
nephritis	nephritis	O	I_disease
and	and	O	O
autoimmune	autoimmune	O	B_disease
hemolytic	hemolytic	O	B_disease
anemia	anemia	O	S_disease
.	.	O	O

Hemolytic	hemolytic	O	B_disease
anemia	anemia	O	S_disease
improved	improved	O	O
after	after	O	O
stopping	stopping	O	O
the	the	O	O
drug	drug	O	O
and	and	O	O
initiation	initiation	O	O
of	of	O	O
steroid	steroid	S_chemical	O
therapy	therapy	O	O
.	.	O	O

Unfortunately	unfortunately	O	O
,	,	O	O
acute	acute	O	B_disease
interstitial	interstitial	O	B_disease
nephritis	nephritis	O	I_disease
was	was	O	O
irreversible	irreversible	O	O
and	and	O	O
the	the	O	O
patient	patient	O	O
developed	developed	O	O
end-stage	end-stage	O	B_disease
renal	renal	O	B_disease
disease	disease	O	I_disease
.	.	O	O

